- NCIt
- C3862
Loading cancer entity…
Loading cancer entity…
Clinical trials
104 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (23)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05501704 | ETHAN - ET for Male BC | recruiting | Phase 2 | 60 | Jose Pablo LeoneOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT07558343 | Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2(MATADOR2) | not yet recruiting | N/A | 120 | Institut Claudius RegaudOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT06422455 |
| Access to Genetic Testing in Underserved Patients With Cancer |
| recruiting |
| N/A |
| 800 |
| University of Southern CaliforniaOTHER |
| 1 |
| Mar 18, 2026 |
| clinicaltrials |
| NCT03384914 | Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer | active not recruiting | Phase 2 | 119 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 6, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 24, 2026source: clinicaltrials